rs140425651

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 3P and 5B. PM1PP3BP4_StrongBP6

The NM_000070.3(CAPN3):​c.2071G>A​(p.Gly691Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000874 in 1,612,362 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Synonymous variant affecting the same amino acid position (i.e. G691G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00020 ( 1 hom., cov: 31)
Exomes 𝑓: 0.000076 ( 0 hom. )

Consequence

CAPN3
NM_000070.3 missense

Scores

9
5
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 8.11

Publications

2 publications found
Variant links:
Genes affected
CAPN3 (HGNC:1480): (calpain 3) Calpain, a heterodimer consisting of a large and a small subunit, is a major intracellular protease, although its function has not been well established. This gene encodes a muscle-specific member of the calpain large subunit family that specifically binds to titin. Mutations in this gene are associated with limb-girdle muscular dystrophies type 2A. Alternate promoters and alternative splicing result in multiple transcript variants encoding different isoforms and some variants are ubiquitously expressed. [provided by RefSeq, Jul 2008]
CAPN3 Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive limb-girdle muscular dystrophy type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae)
  • muscular dystrophy, limb-girdle, autosomal dominant 4
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • muscular dystrophy, limb-girdle, autosomal dominant
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 11 uncertain in NM_000070.3
PP3
Multiple lines of computational evidence support a deleterious effect 11: AlphaMissense, BayesDel_addAF, BayesDel_noAF, Cadd, Dann, FATHMM_MKL, M_CAP, phyloP100way_vertebrate, PROVEAN, REVEL, REVEL [when max_spliceai, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.06506458).
BP6
Variant 15-42409951-G-A is Benign according to our data. Variant chr15-42409951-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 281011.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAPN3NM_000070.3 linkc.2071G>A p.Gly691Arg missense_variant Exon 19 of 24 ENST00000397163.8 NP_000061.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAPN3ENST00000397163.8 linkc.2071G>A p.Gly691Arg missense_variant Exon 19 of 24 1 NM_000070.3 ENSP00000380349.3
CAPN3ENST00000673886.1 linkc.76G>A p.Gly26Arg missense_variant Exon 6 of 11 ENSP00000501155.1
CAPN3ENST00000673928.1 linkc.76G>A p.Gly26Arg missense_variant Exon 6 of 11 ENSP00000501099.1
CAPN3ENST00000674146.1 linkc.76G>A p.Gly26Arg missense_variant Exon 7 of 12 ENSP00000501175.1
CAPN3ENST00000674149.1 linkc.76G>A p.Gly26Arg missense_variant Exon 6 of 11 ENSP00000501112.1
ENSG00000258461ENST00000495723.1 linkn.*2507G>A non_coding_transcript_exon_variant Exon 21 of 26 2 ENSP00000492063.1
CAPN3ENST00000673743.1 linkc.-27G>A 5_prime_UTR_variant Exon 6 of 11 ENSP00000500989.1
ENSG00000258461ENST00000495723.1 linkn.*2507G>A 3_prime_UTR_variant Exon 21 of 26 2 ENSP00000492063.1

Frequencies

GnomAD3 genomes
AF:
0.000210
AC:
32
AN:
152070
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00309
Gnomad SAS
AF:
0.000624
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000195
AC:
49
AN:
251388
AF XY:
0.000177
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00152
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.0000760
AC:
111
AN:
1460174
Hom.:
0
Cov.:
34
AF XY:
0.0000661
AC XY:
48
AN XY:
726338
show subpopulations
African (AFR)
AF:
0.000239
AC:
8
AN:
33424
American (AMR)
AF:
0.00
AC:
0
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.000731
AC:
29
AN:
39698
South Asian (SAS)
AF:
0.000139
AC:
12
AN:
86194
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.000225
AC:
1
AN:
4438
European-Non Finnish (NFE)
AF:
0.0000171
AC:
19
AN:
1111910
Other (OTH)
AF:
0.000681
AC:
41
AN:
60236
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000197
AC:
30
AN:
152188
Hom.:
1
Cov.:
31
AF XY:
0.000188
AC XY:
14
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41526
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00290
AC:
15
AN:
5170
South Asian (SAS)
AF:
0.000416
AC:
2
AN:
4804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68010
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000517
Hom.:
0
Bravo
AF:
0.000242
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000214
AC:
26
Asia WGS
AF:
0.0120
AC:
40
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Autosomal recessive limb-girdle muscular dystrophy type 2A Uncertain:2
Apr 17, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

Oct 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 691 of the CAPN3 protein (p.Gly691Arg). This variant is present in population databases (rs140425651, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with CAPN3-related conditions. ClinVar contains an entry for this variant (Variation ID: 281011). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CAPN3 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

not provided Uncertain:1
Mar 13, 2025
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Oct 16, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.81
BayesDel_addAF
Pathogenic
0.22
D
BayesDel_noAF
Pathogenic
0.47
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.083
T;.;.;D;.;.;.;.;.;.;.;.
Eigen
Uncertain
0.64
Eigen_PC
Uncertain
0.62
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Pathogenic
0.99
D;D;D;D;D;D;.;D;.;D;.;D
M_CAP
Pathogenic
0.33
D
MetaRNN
Benign
0.065
T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Pathogenic
0.94
D
MutationAssessor
Benign
0.0
.;.;.;M;.;.;.;.;.;.;.;.
PhyloP100
8.1
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
0.0
.;D;D;D;D;D;D;.;D;D;D;D
REVEL
Pathogenic
0.92
Sift
Pathogenic
0.0
.;D;D;D;D;D;D;.;D;D;D;D
Sift4G
Uncertain
0.010
D;D;D;D;D;D;D;D;D;D;D;D
Vest4
0.88
ClinPred
0.086
T
GERP RS
4.8
Varity_R
0.55
gMVP
0.75
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140425651; hg19: chr15-42702149; COSMIC: COSV55520484; COSMIC: COSV55520484; API